ZYKADIA
As listed in the register: ZYKADIA 150 MG CAPSULAS DURAS
150 MG · cápsula dura
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Ceritinib
- Made by
- Novartis Europharm Limited
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
Netherlands1 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Novartis Europharm Limited |
|---|---|
| Active substance | Ceritinib |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 150 MG |
| Form | cápsula dura |
| Classification | L01ED02 · Cancer treatments and immune-system medicines |
| Route | vía oral |
| Marketed | Yes, according to the register |
| Driving | The regulator flags that this medicine can affect the ability to drive. |
| Name in the register | ZYKADIA 150 MG CAPSULAS DURAS |
| Nº Registro | 115999001 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.